Trump, Chinese biotech, and an industry career reshaped by illness

On this week’s episode of “The Readout LOUD”: a drug-industry career reshaped by illness, and the potential for political blowback against Chinese biotech.

Listeners of this podcast probably know pharma consultant Mike Rea for his annual ranking of drug company R&D productivity. But this week, he penned a poignant personal essay explaining how some medical setbacks have impacted his professional life. He joins us to discuss.